STOCK TITAN

Ametek SEC Filings

AME NYSE

Welcome to our dedicated page for Ametek SEC filings (Ticker: AME), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The AMETEK, Inc. (NYSE: AME) SEC filings page provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. AMETEK’s common stock is registered under Section 12(b) of the Securities Exchange Act of 1934 and is listed on the New York Stock Exchange under the trading symbol AME, as confirmed in multiple Form 8-K reports.

Among the key filings available are Form 8-K current reports, which AMETEK uses to announce material events. Recent examples include 8-K filings reporting quarterly financial results under Item 2.02, where the company furnishes press releases detailing net sales, operating income, segment performance for the Electronic Instruments Group and Electromechanical Group, and reconciliations of GAAP to non-GAAP measures such as adjusted operating income and adjusted diluted earnings per share. Other 8-K filings disclose events under Item 5.02, such as the planned retirement of a senior vice president and principal accounting officer and the election of a successor, and under Item 8.01 for events like the completion of the FARO Technologies acquisition.

Filings also include a Form 15 relating to the termination or suspension of reporting obligations for plan interests in the Superior Tube Company, Inc. Union 401(k) Plan following its merger into the AMETEK Retirement and Savings Plan. This document clarifies that AMETEK, Inc. common stock remains a class of securities for which reporting duties continue.

On Stock Titan, AME filings are updated as they are released on EDGAR, and AI-powered summaries can help explain the context and key points in lengthy documents. Users can review current reports for earnings announcements, management changes, and acquisition completions, as well as specialized filings like Form 15 related to benefit plans. This page supports investors who want to understand how AMETEK communicates financial performance, governance changes, and corporate actions through its official SEC reporting.

Rhea-AI Summary

AMETEK Inc. chief commercial officer Julie A. Speranza reported equity award vesting and related tax withholding transactions. On March 21, 2025, 404 shares of common stock were acquired at an exercise price of $0 through the vesting of restricted stock units, and 182 shares were disposed of at $174.52 per share to cover taxes. On March 22, 2025, a further 343 shares were acquired at $0, with 155 shares disposed of at $174.52 per share for tax withholding, as noted in the filing.

Following these transactions, Table I shows 31,970 shares of AMETEK common stock held directly. The footnotes state that the restricted stock units vest in three equal annual installments starting on March 19, 2025 and March 22, 2024, and that Ms. Speranza owned 29,270 shares of common stock as of the date this amendment was filed.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

AMETEK’s chief commercial officer, Giovanna M. Speranza, reported equity awards and related share movements. On March 18, 2025 she received 890 restricted stock units and 2,720 stock options, each tied to AMETEK common stock at an exercise price of $176.08.

On March 19, 2025, 230 restricted stock units were converted into common stock at $0, and 104 of those shares were withheld at $177.07 per share to cover taxes. After these transactions she directly owned 31,560 AMETEK common shares, plus 890 restricted stock units, 2,720 stock options, and 460 additional restricted stock units subject to vesting schedules beginning March 18, 2026 and March 22, 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

AMETEK, Inc. announced that its Board of Directors has approved a 10% increase in the quarterly cash dividend on its common stock, raising it to $0.34 per share from $0.31. The first quarter dividend will be payable on March 31, 2026 to shareholders of record as of March 16, 2026.

This increase lifts the company’s indicated annual dividend rate to $1.36 per share, reflecting management’s confidence in AMETEK’s financial strength and ongoing cash generation. The company highlights strong growth, solid cash flow, and a continued focus on strategic acquisitions alongside returning cash to shareholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.81%
Tags
current report
Filing
Rhea-AI Summary

AMETEK, Inc. furnished an update on its performance and strategy by sharing two press releases. The company announced its financial results for the twelve months ended December 31, 2025, highlighting what it describes as record fourth quarter and full year results. These details are contained in a press release attached as an exhibit.

AMETEK also reported that it has acquired LKC Technologies, and provided a separate press release with additional information about this transaction. Both releases are furnished, not filed, meaning they are not automatically incorporated into other securities law filings unless specifically referenced.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.53%
Tags
current report
-
Rhea-AI Summary

AMETEK, Inc. insider holdings are reported for a Senior Vice President and Controller as of 01/06/2026. The reporting person holds 43,747 shares of AMETEK common stock directly, plus 711 common stock units in a SERP account and 3,149 common stock units through a 401(k) plan.

The filing also lists stock options on AMETEK common stock. These include options on 583 shares at an exercise price of $138.46 expiring on 03/22/2033, options on 939 shares at $181.93 expiring on 03/19/2034, and options on 1,381 shares at $176.08 expiring on 03/18/2035. Each grant vests in three equal annual installments beginning on its stated start date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

AMETEK Inc. director reports stock gift

A director of AMETEK Inc. reported a disposition of 1,250 shares of AMETEK common stock on 12/30/2025 coded as "G," indicating a gift transaction. The shares were transferred at a reported price of $0, consistent with a non-cash gift rather than a market sale. Following this transaction, the director beneficially owns 4,690 shares of AMETEK common stock in direct ownership.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

AMETEK Inc. (AME) senior vice president and comptroller reported a small gift of company stock. On 12/26/2025, the officer transferred 19 shares of Common Stock in a transaction coded “G” (gift) at a reported price of $0 per share.

After this transaction, the officer beneficially owns 22,097 shares held directly in a 401(k) plan, 3,441 shares held indirectly through a 401(k) plan common stock/SERP arrangement, and 3,283 shares held directly outside those plans. The filing reports no derivative securities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

AMETEK Inc. officer reports option exercise and share sale. A senior vice president and comptroller exercised stock options for 6,388 shares of AMETEK common stock on 12/22/2025 at an exercise price of $85.45 per share and immediately sold 6,388 shares on the same date. The reported sale price is $205.0548 per share, with actual sale prices ranging from $204.57 to $205.49. After these transactions, the reporting person holds 22,116 AMETEK shares directly and 3,441 shares indirectly through a 401(k) plan. The underlying stock options, which were scheduled to become exercisable in three equal annual installments beginning on May 9, 2020, now show a remaining balance of zero and had an expiration date of May 9, 2029.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

AMETEK, Inc. has filed a notice for the planned sale of 6,388 shares of its common stock through broker Charles Schwab & Co., Inc. on the NYSE. The shares to be sold have an stated aggregate market value of $1,309,890.00. They were acquired on 12/22/2025 via an employee stock option exercise using a broker payment for a cashless exercise on the same date. Shares of AMETEK common stock outstanding were 230,203,873 as of the figures provided; this is a baseline figure, not the amount being sold.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

AMETEK, Inc. reported an insider transaction by its Electronic Instruments president involving company common stock on 12/15/2025. The officer exercised stock options for 14,310 shares of common stock at an exercise price of $63.37 per share; these options became exercisable in three equal annual installments beginning on March 20, 2021.

On the same date, the officer sold 14,310 shares of AMETEK common stock at a price of $202.1131 per share, with sale prices ranging from $202.00 to $202.44. After these transactions, the officer directly owned 42,589 shares, held 3,029 shares through a 401k plan, 348 shares held by a spouse, and 13,553 shares of Common Stock/SERP, with no stock options remaining.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Ametek (AME)?

The current stock price of Ametek (AME) is $233.51 as of February 20, 2026.

What is the market cap of Ametek (AME)?

The market cap of Ametek (AME) is approximately 53.6B.

AME Rankings

AME Stock Data

53.58B
229.28M
Specialty Industrial Machinery
Industrial Instruments for Measurement, Display, and Control
Link
United States
BERWYN

AME RSS Feed